John Fung to Organ Transplantation
This is a "connection" page, showing publications John Fung has written about Organ Transplantation.
Connection Strength
3.897
-
Thomas Earl Starzl (1926-2017). Science. 2017 May 05; 356(6337):491.
Score: 0.442
-
Obituary: The Impact of Thomas Earl Starzl, MD, PhD. Gastroenterology. 2017 Jun; 152(8):1805-1806.
Score: 0.441
-
Thomas Earl Starzl, MD, PhD, Transplant Pioneer, Polymath, Mentor, March 11th, 1926-March 4th, 2017. Transplantation. 2017 05; 101(5):896-897.
Score: 0.441
-
Stromal cell-based immunotherapy in transplantation. Immunotherapy. 2011 Dec; 3(12):1471-85.
Score: 0.303
-
A tribute to Thomas E. Starzl, MD, PHD. Am J Transplant. 2002 Jan; 2(1):4-6.
Score: 0.152
-
Organ allocation in the United States: where does it stand? Point. J Am Coll Surg. 2001 Jan; 192(1):118-24.
Score: 0.142
-
Use of non-heart-beating donors. Transplant Proc. 2000 Nov; 32(7):1510-1.
Score: 0.141
-
Understanding and preventing late graft loss. Transplant Proc. 2000 Nov; 32(7):1514.
Score: 0.141
-
Call for an End to Unethical Transplant Practices: A Concerted Effort by the Transplant Community. Transplantation. 2019 04; 103(4):647.
Score: 0.126
-
Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. Am J Transplant. 2018 10; 18(10):2544-2558.
Score: 0.118
-
FK506 in solid organ transplantation. Ther Drug Monit. 1995 Dec; 17(6):592-5.
Score: 0.100
-
Open letter to Xi Jinping, President of the People's Republic of China: China's fight against corruption in organ transplantation. Transplantation. 2014 Apr 27; 97(8):795-6.
Score: 0.090
-
China organ donation and transplantation update: the Hangzhou Resolution. Hepatobiliary Pancreat Dis Int. 2014 Apr; 13(2):122-4.
Score: 0.089
-
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993 Jun; 17(6):1127-52.
Score: 0.084
-
Patient participation in research among solid organ transplant recipients in the United States. Transplantation. 2011 Jun 27; 91(12):1424-35.
Score: 0.074
-
The many faces of multivisceral transplantation. Surg Gynecol Obstet. 1991 May; 172(5):335-44.
Score: 0.073
-
Transplant tourism and unregulated black-market trafficking of organs. Am J Transplant. 2009 Jun; 9(6):1484.
Score: 0.064
-
Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion. Cleve Clin J Med. 2008 Nov; 75 Suppl 6:S24-9; discussion S30-2.
Score: 0.061
-
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant. 2006; 6(5 Pt 2):1111-31.
Score: 0.050
-
EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. Transpl Immunol. 2005 Jun; 14(2):109-16.
Score: 0.048
-
Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation. 2005 Feb 27; 79(4):451-9.
Score: 0.047
-
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002 Sep; 81(5):333-48.
Score: 0.040
-
Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002 Aug; 2(7):575-80.
Score: 0.040
-
Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002 Mar; 2(3):287-91.
Score: 0.039
-
Development and experience with an integrated system for transplantation telepathology. Hum Pathol. 2001 Dec; 32(12):1334-43.
Score: 0.038
-
Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation. 2001 Jan 15; 71(1):64-9.
Score: 0.036
-
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000 Mar; 24(3):375-85.
Score: 0.034
-
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation. 1999 Nov 27; 68(10):1517-25.
Score: 0.033
-
Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol. 1999 Aug; 66(2):310-4.
Score: 0.032
-
Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders. Clin Transplant. 1999 Feb; 13(1 Pt 1):39-44.
Score: 0.031
-
Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc. 1998 Jun; 30(4):1367-8.
Score: 0.030
-
Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
Score: 0.029
-
The immunolymphatic theory of chronic rejection. Transplant Proc. 1997 Sep; 29(6):2615-6.
Score: 0.028
-
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc. 1997 May; 29(3):1905-6.
Score: 0.028
-
Chimerism after organ transplantation. Curr Opin Nephrol Hypertens. 1997 May; 6(3):292-8.
Score: 0.028
-
The bidirectional paradigm of transplant immunology. Ann N Y Acad Sci. 1995 Dec 29; 770:165-76.
Score: 0.025
-
The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp. 1995; 24:341-54.
Score: 0.023
-
Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan; 180(1):1-9.
Score: 0.023
-
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991 Jul; 52(1):71-7.
Score: 0.018
-
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. Transplant Proc. 1991 Feb; 23(1 Pt 2):1108-10.
Score: 0.018
-
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc. 1991 Feb; 23(1 Pt 2):914-9.
Score: 0.018
-
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 1990 Nov; 108(5):880-9.
Score: 0.018
-
De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004 Jun 15; 77(11):1719-25.
Score: 0.011
-
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol. 2003 Aug; 64(8):787-95.
Score: 0.011
-
Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. Ther Drug Monit. 2001 Aug; 23(4):354-62.
Score: 0.009
-
Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg. 1999 Apr-Jun; 62(2):244-7.
Score: 0.008
-
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
Score: 0.007
-
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995 Jul 27; 60(2):158-71.
Score: 0.006
-
Three years clinical experience with intestinal transplantation. J Am Coll Surg. 1994 Oct; 179(4):385-400.
Score: 0.006
-
Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet. 1993 Mar; 176(3):297-8.
Score: 0.005